Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $84.9800 (-1.21%) ($83.8200 - $85.5700) on Mon. Mar. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 48 | Latest Price | $84.9800(-1.21%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BAX advances 0.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(36%) VYM(35%) SPLV(34%) XLP(34%) SDY(33%) | Factors Impacting BAX price | BAX will decline at least -0.56% in a week (0% probabilities). VIXM(-21%) UUP(-21%) EDOC(-3%) TBT(-1%) VXX(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | -0.6 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $85.52 | 5 Day Moving Average | $85.11(-0.15%) | 10 Day Moving Average | $85.17(-0.22%) | 20 Day Moving Average | $85.52(-0.63%) | To recent high | -5% | To recent low | 6.4% | Market Cap | $43.355b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |